Wall Street Zen Downgrades HealthEquity (NASDAQ:HQY) to Hold

HealthEquity (NASDAQ:HQY) was downgraded by stock analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Sunday.

Other equities research analysts have also recently issued research reports about the stock. Citigroup reissued an “outperform” rating on shares of HealthEquity in a report on Thursday, December 4th. BTIG Research reiterated a “buy” rating and issued a $130.00 price target on shares of HealthEquity in a research report on Thursday, December 4th. Weiss Ratings reissued a “hold (c+)” rating on shares of HealthEquity in a report on Wednesday, October 8th. Citizens Jmp raised their target price on HealthEquity from $117.00 to $122.00 and gave the stock a “market outperform” rating in a research note on Thursday, December 4th. Finally, The Goldman Sachs Group downgraded shares of HealthEquity from a “neutral” rating to a “sell” rating and set a $89.00 price target on the stock. in a report on Friday. Two investment analysts have rated the stock with a Strong Buy rating, twelve have assigned a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $119.60.

HealthEquity Price Performance

Shares of NASDAQ:HQY opened at $94.15 on Friday. The firm has a market capitalization of $8.04 billion, a PE ratio of 43.19, a P/E/G ratio of 1.36 and a beta of 0.20. The company has a quick ratio of 4.13, a current ratio of 4.13 and a debt-to-equity ratio of 0.46. The company has a 50-day moving average price of $97.04 and a two-hundred day moving average price of $95.20. HealthEquity has a twelve month low of $74.07 and a twelve month high of $116.65.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings results on Wednesday, December 3rd. The company reported $1.01 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.90 by $0.11. The company had revenue of $322.16 million for the quarter, compared to analyst estimates of $320.92 million. HealthEquity had a net margin of 14.86% and a return on equity of 12.94%. The company’s quarterly revenue was up 7.2% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.78 earnings per share. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. Equities analysts forecast that HealthEquity will post 2.32 EPS for the current year.

Insider Activity

In related news, EVP Elimelech Rosner sold 10,959 shares of the company’s stock in a transaction that occurred on Thursday, December 18th. The shares were sold at an average price of $95.45, for a total value of $1,046,036.55. Following the transaction, the executive vice president directly owned 45,742 shares in the company, valued at approximately $4,366,073.90. This represents a 19.33% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Delano Ladd sold 1,500 shares of the firm’s stock in a transaction that occurred on Friday, December 19th. The shares were sold at an average price of $94.72, for a total transaction of $142,080.00. Following the completion of the sale, the executive vice president directly owned 73,979 shares in the company, valued at $7,007,290.88. This represents a 1.99% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last ninety days, insiders sold 15,459 shares of company stock worth $1,483,062. Insiders own 1.50% of the company’s stock.

Hedge Funds Weigh In On HealthEquity

Institutional investors have recently made changes to their positions in the stock. Farther Finance Advisors LLC increased its stake in HealthEquity by 232.4% in the 2nd quarter. Farther Finance Advisors LLC now owns 246 shares of the company’s stock worth $26,000 after purchasing an additional 172 shares during the period. Caitong International Asset Management Co. Ltd bought a new position in shares of HealthEquity in the second quarter worth approximately $33,000. True Wealth Design LLC increased its stake in shares of HealthEquity by 3,522.2% in the third quarter. True Wealth Design LLC now owns 326 shares of the company’s stock worth $31,000 after buying an additional 317 shares during the period. Cullen Frost Bankers Inc. raised its holdings in HealthEquity by 172.3% during the 2nd quarter. Cullen Frost Bankers Inc. now owns 354 shares of the company’s stock valued at $37,000 after buying an additional 224 shares during the last quarter. Finally, Sellwood Investment Partners LLC bought a new stake in HealthEquity during the 2nd quarter valued at $58,000. Institutional investors own 99.55% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.